Incyte Corporation (INCY) Nasdaq Global Select
CloseJanuary 18, 2019

News: updated – 21-Jan 06:20

Oppenheimer likes VBI Vaccines in premarket analyst action16-Jan 07:29(SeekingAlpha)

VBI Vaccines (NASDAQ: VBIV ) initiated with Outperform rating and $9 (408% upside) price target at Oppenheimer. More news on: VBI Vaccines, ViewRay, Incyte Corporation, Healthcare stocks news, Stocks on the move, , Read more …